Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 328 of 1,261

  1. US 11066433

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Galera Labs, LLC · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  2. US 11066444

    BMP-2-binding peptide amphiphile nanofibers

    Northwestern University · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  3. US 11066405

    Bicyclic compounds and their use in the treatment of cancer

    TEMPEST THERAPEUTICS, INC. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  4. US 11066371

    Pyridine compound, making, and use thereof

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  5. US 11066362

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  6. US 11066378

    Caffeic acid derivatives for anti-angiogenesis

    China Medical University · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  7. US 11066360

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  8. US 11066417

    Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators

    Vertex Pharmaceuticals Incorporated · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  9. US 11065332

    Combination therapy of immunotoxin and checkpoint inhibitor

    The Government of The United States as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  10. US 11065330

    Induction of antigen-specific tolerance by peripheral phagocytosis

    PLS-Design GmbH · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  11. US 11065327

    Human rotavirus strains and vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  12. US 11065285

    Biomarkers and combination therapies using oncolytic virus and immunomodulation

    The Board of Regents of the University of Texas System · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  13. US 11065299

    Compositions and methods for modulation of immune response

    Northwestern University · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  14. US 11065340

    Polyoxazoline antibody drug conjugates

    Serina Therapeutics, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  15. US 11065264

    Metal-olsalazine coordination polymers for medical applications

    The Regents of the University of California · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  16. US 11065280

    Hepatocytes with high regenerative capacity for liver repair

    The Regents of the University of California · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  17. US 11065267

    Lysophosphatidylcholine compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  18. US 11065237

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  19. US 11065254

    Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  20. US 11065218

    Compositions and methods for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  21. US 11065214

    Combination therapies with disulfiram

    Spring Discovery, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  22. US 11065204

    Oxidized cellulose microspheres

    Covidien LP · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  23. US 11065197

    Soluble estradiol capsule for vaginal insertion

    Compass Therapeutics LLC · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  24. US 11064685

    Non-human animal models of retinoschisis

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.